Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women
Authors
Keywords
-
Journal
Reproductive Sciences
Volume 22, Issue 7, Pages 774-782
Publisher
SAGE Publications
Online
2014-09-17
DOI
10.1177/1933719114549845
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced Glycation End-Products: Pathway of Potentially Significant Pathophysiological and Therapeutic Relevance for Metabolic Syndrome in Menopausal Women
- (2014) Zaher Merhi JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
- (2013) Keiko Fujisawa et al. ATHEROSCLEROSIS
- Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes
- (2013) Kelly J. Hunt et al. ATHEROSCLEROSIS
- Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity
- (2013) Nattha Jariyapamornkoon et al. BMC Complementary and Alternative Medicine
- Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasma
- (2013) Norma Frizzell et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
- (2013) Katarína Šebeková et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
- (2013) E. Selvin et al. DIABETES
- Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients
- (2013) Savita Bansal et al. GENE
- Advanced glycation end products: role in pathology of diabetic cardiomyopathy
- (2013) Vijaya Lakshmi Bodiga et al. HEART FAILURE REVIEWS
- Advanced glycation end products and their relevance in female reproduction
- (2013) Z. Merhi HUMAN REPRODUCTION
- Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis
- (2013) CHANG HOON HA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Statins stimulate the production of a soluble form of the receptor for advanced glycation end products
- (2013) Patricia Quade-Lyssy et al. JOURNAL OF LIPID RESEARCH
- Isoferulic Acid, a New Anti-Glycation Agent, Inhibits Fructose- and Glucose-Mediated Protein Glycation in Vitro
- (2013) Aramsri Meeprom et al. MOLECULES
- Inhibitory Effect of Metformin and Pyridoxamine in the Formation of Early, Intermediate and Advanced Glycation End-Products
- (2013) Saheem Ahmad et al. PLoS One
- Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
- (2013) Colomba Falcone et al. TheScientificWorldJOURNAL
- Update on Potential Drugs for the Treatment of Diabetic Kidney Disease
- (2012) Brian Shepler et al. CLINICAL THERAPEUTICS
- Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
- (2012) G. J.S. Cooper CURRENT MEDICINAL CHEMISTRY
- Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications
- (2012) R. Nagai et al. DIABETES
- Cinnamic Acid and Its Derivatives Inhibit Fructose-Mediated Protein Glycation
- (2012) Sirichai Adisakwattana et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases
- (2012) Christina Piperi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Exercise on sRAGE Levels and Cardiometabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized Controlled Trial
- (2012) Kyung Mook Choi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk
- (2012) Colomba Falcone et al. JOURNAL OF NEPHROLOGY
- Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
- (2012) W. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial
- (2011) H. M. Colhoun et al. DIABETES
- Serum advanced glycation end products (AGEs) are associated with insulin resistance
- (2011) Kathryn C. B. Tan et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats
- (2011) Lin Lu et al. Journal of Zhejiang University-SCIENCE B
- Relationship of methylglyoxal-adduct biogenesis to LDL and triglyceride levels in diabetics
- (2011) Zdenka Turk et al. LIFE SCIENCES
- Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue
- (2011) C. Hu et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Advanced glycation endproducts: from precursors to RAGE: round and round we go
- (2010) Ravichandran Ramasamy et al. AMINO ACIDS
- RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo
- (2010) D. Frommhold et al. BLOOD
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Levels of Oxidized LDL and Advanced Glycation End Products-Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
- (2010) M. F. Lopes-Virella et al. DIABETES
- Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet
- (2010) Jaime Uribarri et al. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
- Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women
- (2010) Genevieve A. Woodard et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Lipid Changes During the Menopause Transition in Relation to Age and Weight: The Study of Women's Health Across the Nation
- (2009) C. A. Derby et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease
- (2009) Nitin Mahajan et al. ATHEROSCLEROSIS
- Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes
- (2009) H.L. Tam et al. ATHEROSCLEROSIS
- Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen
- (2009) Kuo-Chu Chang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients
- (2009) Kuang-Hsing Chiang et al. CORONARY ARTERY DISEASE
- Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1
- (2009) Helen Vlassara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response
- (2009) Shi Fang Yan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?
- (2009) Karen A. Matthews et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial
- (2009) R. Pullerits et al. RHEUMATOLOGY
- Advanced Glycation End Products and Insulin Resistance
- (2008) Hiroyuki Unoki et al. CURRENT PHARMACEUTICAL DESIGN
- Clinical Relevance of Advanced Glycation Endproducts for Vascular Surgery
- (2008) R. Meerwaldt et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population
- (2008) Giuseppe Danilo Norata et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started